טוען...
Agonist antibodies to TNFR molecules that costimulate T and NK cells
Therapy of cancer can be achieved by artificially stimulating anti-tumor T and NK lymphocytes with agonist monoclonal antibodies. T and NK cells express several members of the Tumor Necrosis Factor-receptor (TNFR) family specialized in delivering a costimulatory signal on their surface. Engagement o...
שמור ב:
| הוצא לאור ב: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4397897/ https://ncbi.nlm.nih.gov/pubmed/23460535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2065 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|